|
시장보고서
상품코드
2075131
무세포 진피 매트릭스 시장 : 원료별, 용도별, 이식 부위별 및 지역별Acellular Dermal Matrices Market, By Origin, By Application, By Place of Setting, and By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
무세포 진피 매트릭스 시장은 2026년에 124억 1,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 279억 5,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.3%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 124억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.30% | 2033년 시장 규모 예측 : | 279억 5,000만 달러 |
무세포 진피 매트릭스는 탈세포화 과정을 통해 생성됩니다. 이 과정을 통해 세포가 제거되고, 세포외 기질이 보존됩니다. 필요한 부위에 이식된 세포외 기질은 기증 세포를 위한 지지체 역할을 합니다. 기증 세포는 재혈관화를 촉진하며, 그 결과 새로운 조직이 형성됩니다.
시장 역학:
여성 인구 중 유방암 유병률이 증가함에 따라 유방 절제술 시행률이 높아질 것으로 예상됩니다. 그 결과, 예측 기간 중 무세포 진피 매트릭스 시장의 성장이 가속화될 것으로 전망됩니다. 예를 들어 세계보건기구(WHO)에 따르면 2019년 인도의 유방암 환자 수는 약 209만 명, 사망자 수는 62만 7,000명에 달했습니다. 이는 인도에서 가장 흔한 암 유형로, 여성 암 전체의 약 14%를 차지합니다. 인도에서는 발병률이 30대 초반부터 상승하기 시작해, 50-64세에 정점에 달하는 것으로 추정됩니다.
각국에서 무세포 진피 매트릭스 제품의 입수 가능성이 높아짐에 따라 고객 기반이 확대될 것으로 예상되며, 그 결과 예측 기간 중 전 세계 무세포 진피 매트릭스 시장의 성장이 촉진될 것으로 전망됩니다. 예를 들어 2016년에는 상처 치료 및 재생 의료 기업인 Acelity L.P. Inc.가 미국에서 재생 조직 매트릭스 ‘ALLODERM SELECT DUO'를 발매했습니다. 이번 출시로 인해 양측 유방 재건술을 받는 미국 환자들에게 이 조직 매트릭스를 구하기가 더 쉬워질 것입니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 무세포 진피 매트릭스 시장의 주요 기업 개요을 소개하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 이 보고서에서 도출된 인사이트는 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있도록 해줍니다.
- 이 '세계의 무세포 진피 매트릭스 시장' 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 무세포 진피 매트릭스 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 무세포 진피 매트릭스 시장 : 유래별, 2021-2033년
제5장 세계의 무세포 진피 매트릭스 시장 : 용도별, 2021-2033년
제6장 세계의 무세포 진피 매트릭스 시장 : 설치 장소별, 2021-2033년
제7장 세계의 무세포 진피 매트릭스 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSAAcellular Dermal Matrices Market is estimated to be valued at USD 12.41 Bn in 2026 and is expected to reach USD 27.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.41 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.30% | 2033 Value Projection: | USD 27.95 Bn |
Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue.
Market Dynamics:
The increasing prevalence of breast cancer among the women population is expected to increase the rates of masectomy, which in turn is expected to drive growth of the acellular dermal matrices market growth over the forecast period. For instance, in 2019, according to the World Health Organization (WHO), in India, breast cancer accounts for around 2.09 million cases and 627,000 deaths. It is the most common type of cancer in India and accounts for around 14% of all the cancers in women. It has been estimated that, in India, the incidence rate increases in early thirties and are at its peak at the ages 50-64 years.
Increasing availability of the acellular dermal matrices products in different countries is expected to increase the customer base, which in turn will drive the global acellular dermal matrices market growth over the forecast period. For instance, in 2016, Acelity L.P. Inc., a wound care and regenerative medicine company launched ALLODERM SELECT DUO regenerative tissue matrix in the U.S. The launch will increase the availability of the tissue matrix for the U.S. population undergoing bilateral breast reconstruction.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global acellular dermal matrices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations, Medtronic, Inc., Synthes, Inc., Gunze Corp., Cook Medical Incorporated, C. R. Bard, Inc., and HANS BIOMED CORP.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the acellular dermal matrices market
Detailed Segmentation:
- Global Acellular Dermal Matrices Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- Global Acellular Dermal Matrices Market, By Tissue Origin (Revenue, USD Bn, 2021 - 2033)
- Human
- Porcine
- Bovine
- Others
- Global Acellular Dermal Matrices Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- Global Acellular Dermal Matrices Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Country
- U.S.
- Canada
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- By Country
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- By Country:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Material Type:
- Polyhydroxyalkanoate (PHA)
- Silicone
- Dispersants
- Others
- By Tissue Origin
- Human
- Porcine
- Bovine
- Others
- By Application
- Orthopedics
- Plastic Surgery
- General Surgery
- Repair and Replacement of Tissue (Wound Coverage)
- Dental
- Others
- By Country/Region:
- Company Profiles
- Zimmer Biomet*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Stryker Corporation
- Staumann, Allergan, Inc.
- Conmed
- Integra LifeSciences Corporation
- Aziyo Biologics
- Hospital Innovations
- Medtronic, Inc.
- Synthes, Inc.
- Gunze Corp.
- Cook Medical Incorporated
- R. Bard, Inc.
- HANS BIOMED CORP.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Origin
- Market Snippet, By Application
- Market Snippet, By Place of Setting
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Recent Trend
- Key Developments
- Regulatory Scenario
- PEST Analysis
- PORTER's Analysis
- Product Launches/Approvals Mergers, Acquisitions and Collaborations
4. Global Acellular Dermal Matrices Market, By Origin, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Human Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Porcine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Bovine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
5. Global Acellular Dermal Matrices Market, By Application, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Burns
- Trauma
- Cancers
- Infections
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcer
- Others
- Reconstruction Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Abdominal Wall Procedures
- Breast Procedures
- Orthopedic Procedures
- Others
6. Global Acellular Dermal Matrices Market, By Place of Setting, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- In- patient
- Out- patient
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Office Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
7. Global Acellular Dermal Matrices Market, By Region, 2021-2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 -2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Integra LifeSciences Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- HansBioMed
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cook Group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Smith & Nephew Plc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Reprise Biomedical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Organogenesis Holdings Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Tissue Regenix
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- LifeNet Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- MiMedx Group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- PolyNovo Limited
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fidia Pharma USA Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- In2Bones Global
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioHorizons, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Harbor MedTech, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MLM Biologics Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Geistlich Pharma AG
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Olaregen Therapeutix, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- EnColl Corporation
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kerecis limited
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- DSM
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ACell Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- 3M
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cell Constructs I, LLC
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CG bio Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Marine Polymer Technologies, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Integra LifeSciences Corporation
- Analysts' Views
9. Section
- Research Methodology
- About us and Sales Contact
